{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:09:29Z","timestamp":1767823769198,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10549-025-07866-5","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:37:55Z","timestamp":1764945475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer"],"prefix":"10.1007","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3578-029X","authenticated-orcid":false,"given":"Danielle","family":"Laperche-Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Assad-Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heloisa","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Cesar","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulene Cunha Sousa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Kazumi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Arakelian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Luiza Zapalowski","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Santos Wance","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Guimar\u00e3es Castro","family":"Custodio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monalisa Ceciliana Freitas Moreira","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri Cardoso Rodrigues Beckedorff","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina Figueroa","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"de P\u00e1dua Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poliana Albuquerque","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Jessica","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lica","family":"Nogueira-Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Dornelles","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romualdo","family":"Barroso-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"7866_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/IJC.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M et al (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941\u20131953. https:\/\/doi.org\/10.1002\/IJC.31937","journal-title":"Int J Cancer"},{"key":"7866_CR2","unstructured":"Instituto Nacional de C\u00e2ncer \u2013 INCA. Estimativa 2023\u202f: Incid\u00eancia de C\u00e2ncer no Brasil 2022. https:\/\/www.gov.br\/inca\/pt-br\/assuntos\/cancer\/numeros\/estimativa (accessed April 9, 2022)."},{"key":"7866_CR3","unstructured":"IBGE\/Datasus. Ag\u00eancia Nacional de Sa\u00fade Suplementar: Dados Gerais. Brazil (2023) 2024. https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/perfil-do-setor\/dados-gerais (accessed February 15, 2024)."},{"key":"7866_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10549-020-05831-y","volume":"183","author":"DD Rosa","year":"2020","unstructured":"Rosa DD, Bines J, Werutsky G, Barrios CH, Cronemberger E, Queiroz GS et al (2020) The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115). Breast Cancer Res Treat 183:749\u2013757. https:\/\/doi.org\/10.1007\/s10549-020-05831-y","journal-title":"Breast Cancer Res Treat"},{"key":"7866_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.breast.2019.01.008","volume":"44","author":"SD Simon","year":"2019","unstructured":"Simon SD, Bines J, Werutsky G, Nunes JS, Pacheco FC, Segalla JG et al (2019) Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: the AMAZONA retrospective cohort study. Breast 44:113\u2013119. https:\/\/doi.org\/10.1016\/j.breast.2019.01.008","journal-title":"Breast"},{"key":"7866_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1023\/A:1006263818115","volume":"55","author":"LJ Fallowfield","year":"1999","unstructured":"Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55:187\u2013197. https:\/\/doi.org\/10.1023\/A:1006263818115","journal-title":"Breast Cancer Res Treat"},{"key":"7866_CR7","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.ejon.2004.09.005","volume":"8","author":"LJ Fallowfield","year":"2004","unstructured":"Fallowfield LJ (2004) Evolution of breast cancer treatments: current options and quality-of-life considerations. Eur J Oncol Nurs 8:S75-82. https:\/\/doi.org\/10.1016\/j.ejon.2004.09.005","journal-title":"Eur J Oncol Nurs"},{"key":"7866_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01591-x","author":"P Mokhatri-Hesari","year":"2020","unstructured":"Mokhatri-Hesari P, Montazeri A (2020) Health-related quality of life in breast cancer patients: Review of reviews from 2008 to 2018. Health Qual Life Outcomes. https:\/\/doi.org\/10.1186\/s12955-020-01591-x","journal-title":"Health Qual Life Outcomes"},{"key":"7866_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1200\/jop.2005.1.1.35","volume":"1","author":"E Stovall","year":"2005","unstructured":"Stovall E (2005) National Coalition for Cancer Survivorship: advocating for quality cancer care for all. J Oncol Pract 1:35\u201335. https:\/\/doi.org\/10.1200\/jop.2005.1.1.35","journal-title":"J Oncol Pract"},{"key":"7866_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/cncr.33937","volume":"128","author":"M Doose","year":"2022","unstructured":"Doose M, Mollica MA, Attai DJ, Nasso SF, Elena JW, Jacobsen PB et al (2022) Identifying and describing cancer survivors: implications for cancer survivorship research and clinical care. Cancer 128:383\u2013390. https:\/\/doi.org\/10.1002\/cncr.33937","journal-title":"Cancer"},{"key":"7866_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"7866_CR12","unstructured":"Michels FAS, Latorre MRDO, Maciel MS, Alessandra F, Michels S. Validation, Reliability and Comprehension of the IBCSG Quality of Life Questionnaire Specific to Breast Cancer. vol. 30. 2010."},{"key":"7866_CR13","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","volume":"14","author":"MA Sprangers","year":"1996","unstructured":"Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756\u20132768. https:\/\/doi.org\/10.1200\/JCO.1996.14.10.2756","journal-title":"J Clin Oncol"},{"key":"7866_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J Natl Cancer Inst 85:365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"JNCI J Natl Cancer Inst"},{"key":"7866_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/cer.14.76","volume":"4","author":"J Nguyen","year":"2015","unstructured":"Nguyen J, Popovic M, Chow E, Cella D, Beaumont JL, Chu D et al (2015) EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review. J Comp Eff Res 4:157\u2013166. https:\/\/doi.org\/10.2217\/cer.14.76","journal-title":"J Comp Eff Res"},{"key":"7866_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10549-020-06062-x","volume":"186","author":"L Aptecar","year":"2021","unstructured":"Aptecar L, Fiteni F, Jarlier M, Delaine S, Guillerme V, Jacot W et al (2021) Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient\u2019s dedicated questionnaire: a glaring gap of communication between health professionals and patients. Breast Cancer Res Treat 186:705\u2013713. https:\/\/doi.org\/10.1007\/s10549-020-06062-x","journal-title":"Breast Cancer Res Treat"},{"key":"7866_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s12094-019-02048-4","volume":"21","author":"JI Arraras","year":"2019","unstructured":"Arraras JI, Illarramendi JJ, Manterola A, Asin G, Salgado E, Arrondo P et al (2019) Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study. Clin Transl Oncol 21:1231\u20131239. https:\/\/doi.org\/10.1007\/s12094-019-02048-4","journal-title":"Clin Transl Oncol"},{"key":"7866_CR18","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/j.clbc.2021.09.012","volume":"22","author":"L Benoit","year":"2022","unstructured":"Benoit L, Cambra C, Rouzier R, Cottu P, Rodrigues M, Reyal F et al (2022) Quality of life in an e-cohort of women treated by endocrine therapy for early breast cancer. Clin Breast Cancer 22:e352\u2013e361. https:\/\/doi.org\/10.1016\/j.clbc.2021.09.012","journal-title":"Clin Breast Cancer"},{"key":"7866_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/CCO.0000000000000781","volume":"33","author":"A Di Meglio","year":"2021","unstructured":"Di Meglio A, Soldato D, Presti D, Vaz-Luis I (2021) Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy. Curr Opin Oncol 33:553\u2013573. https:\/\/doi.org\/10.1097\/CCO.0000000000000781","journal-title":"Curr Opin Oncol"},{"key":"7866_CR20","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/annonc\/mdz298","volume":"30","author":"AR Ferreira","year":"2019","unstructured":"Ferreira AR, Di Meglio A, Pistilli B, Gbenou AS, El-Mouhebb M, Dauchy S et al (2019) Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol 30:1784\u20131795. https:\/\/doi.org\/10.1093\/annonc\/mdz298","journal-title":"Ann Oncol"},{"key":"7866_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11136-021-02885-3","volume":"31","author":"L Guti\u00e9rrez-Hermoso","year":"2022","unstructured":"Guti\u00e9rrez-Hermoso L, Velasco-Furlong L, S\u00e1nchez-Rom\u00e1n S, Berzal-P\u00e9rez E, Alcocer-Castillejos N, Quiroz-Friedman P (2022) The effect of treatment and coping on the quality of life in breast cancer patients: a moderated mediation model. Qual Life Res 31:147\u2013158. https:\/\/doi.org\/10.1007\/s11136-021-02885-3","journal-title":"Qual Life Res"},{"key":"7866_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.breast.2006.11.003","volume":"16","author":"P Hopwood","year":"2007","unstructured":"Hopwood P, Haviland J, Mills J, Sumo G, Bliss JM (2007) The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START trial (standardisation of breast radiotherapy trial). Breast 16:241\u2013251. https:\/\/doi.org\/10.1016\/j.breast.2006.11.003","journal-title":"Breast"},{"key":"7866_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000500771","volume":"15","author":"C Jackisch","year":"2020","unstructured":"Jackisch C, Kreienberg R, Blettner M, Harbeck N, L\u00fcck HJ, Haidinger R et al (2020) Assessment of quality of life in postmenopausal women with early breast cancer participating in the PACT trial: the impact of additional patient information material packages and patient compliance. Breast Care 15:236\u2013245. https:\/\/doi.org\/10.1159\/000500771","journal-title":"Breast Care"},{"key":"7866_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.breast.2015.01.010","volume":"24","author":"M Kool","year":"2015","unstructured":"Kool M, Fontein DBY, Meershoek-Klein Kranenbarg E, Nortier JWR, Rutgers EJT, van de Marang- Mheen PJ et al (2015) Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients. Breast 24:224\u2013229. https:\/\/doi.org\/10.1016\/j.breast.2015.01.010","journal-title":"Breast"},{"key":"7866_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10549-022-06583-7","volume":"193","author":"AA Lemij","year":"2022","unstructured":"Lemij AA, de Glas NA, Derks MGM, Bastiaannet E, Merkus JWS, Lans TE et al (2022) Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer. Breast Cancer Res Treat 193:567\u2013577. https:\/\/doi.org\/10.1007\/s10549-022-06583-7","journal-title":"Breast Cancer Res Treat"},{"key":"7866_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bjs\/znaa125","volume":"108","author":"JL Morgan","year":"2021","unstructured":"Morgan JL, Shrestha A, Reed MWR, Herbert E, Bradburn M, Walters SJ et al (2021) Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes. Br J Surg 108:315\u2013325. https:\/\/doi.org\/10.1093\/bjs\/znaa125","journal-title":"Br J Surg"},{"key":"7866_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10549-012-2028-2","volume":"134","author":"JGH Van Nes","year":"2012","unstructured":"Van Nes JGH, Fontein DBY, Hille ETM, Voskuil DW, Van Leeuwen FE, De Haes JCJM et al (2012) Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial side study. Breast Cancer Res Treat 134:267\u2013276. https:\/\/doi.org\/10.1007\/s10549-012-2028-2","journal-title":"Breast Cancer Res Treat"},{"key":"7866_CR28","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/annonc\/mdq151","volume":"21","author":"DW Voskuil","year":"2010","unstructured":"Voskuil DW, van Nes JGH, Junggeburt JMC, van de Velde CJH, van Leeuwen FE, de Haes JCJM (2010) Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients. Ann Oncol 21:2094\u20132101. https:\/\/doi.org\/10.1093\/annonc\/mdq151","journal-title":"Ann Oncol"},{"key":"7866_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187165","author":"F Laroche","year":"2017","unstructured":"Laroche F, Perrot S, Medkour T, Cottu PH, Pierga JY, Lotz JP et al (2017) Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0187165","journal-title":"PLoS ONE"},{"key":"7866_CR30","first-page":"89","volume":"9","author":"J Pais-Ribeiro","year":"2008","unstructured":"Pais-Ribeiro J, Pinto C, Santos &C (2008) Validation study of the Portuguese version of the QLC-C30-V.3. Psicologia, Sa\u00fade & Doen\u00e7as 9:89\u2013102","journal-title":"Psicologia, Sa\u00fade & Doen\u00e7as"},{"key":"7866_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1590\/S1415-790X2013000200011","volume":"16","author":"FAS Michels","year":"2013","unstructured":"Michels FAS, Latorre MdoRDdeO, Maciel MdoS (2013) Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol 16:352\u2013363. https:\/\/doi.org\/10.1590\/S1415-790X2013000200011","journal-title":"Rev Bras Epidemiol"},{"key":"7866_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1158\/1055-9965.EPI-13-0693","volume":"23","author":"PER Liedke","year":"2014","unstructured":"Liedke PER, Finkelstein DM, Szymonifka J, Barrios CH, Chavarri-Guerra Y, Bines J et al (2014) Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study. Cancer Epidemiol Biomarkers Prev 23:126\u2013133. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0693","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7866_CR33","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1016\/S1470-2045(11)70323-0","volume":"13","author":"BL Lee","year":"2012","unstructured":"Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE (2012) Breast cancer in Brazil: present status and future goals. Lancet Oncol 13:e95-102. https:\/\/doi.org\/10.1016\/S1470-2045(11)70323-0","journal-title":"Lancet Oncol"},{"key":"7866_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(19)31243-7","volume":"394","author":"MC Castro","year":"2019","unstructured":"Castro MC, Massuda A, Almeida G, Menezes-Filho NA, Andrade MV, de Souza Noronha KVM et al (2019) Brazil\u2019s unified health system: the first 30 years and prospects for the future. Lancet 394:345\u2013356. https:\/\/doi.org\/10.1016\/S0140-6736(19)31243-7","journal-title":"Lancet"},{"key":"7866_CR35","doi-asserted-by":"crossref","unstructured":"Burstein HJ, Somerfield MR, Barton DL, Dorris A, Fallowfield LJ, Jain D, et al. Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update. 2021.","DOI":"10.1200\/JCO.21.01392"},{"key":"7866_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-016-0446-2","author":"A Cao","year":"2016","unstructured":"Cao A, Zhang J, Liu X, Wu W, Liu Y, Fan Z et al (2016) Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study. Health Qual Life Outcomes. https:\/\/doi.org\/10.1186\/s12955-016-0446-2","journal-title":"Health Qual Life Outcomes"},{"key":"7866_CR37","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1200\/JCO.2007.14.0228","volume":"26","author":"EP Mamounas","year":"2008","unstructured":"Mamounas EP, Jeong JH, Lawrence Wickerham D, Smith RE, Ganz PA, Land SR et al (2008) Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: Intention-to-treat analysis of the national surgical adjuvant breast and bowel project B-33 trial. J Clin Oncol 26:1965\u20131971. https:\/\/doi.org\/10.1200\/JCO.2007.14.0228","journal-title":"J Clin Oncol"},{"key":"7866_CR38","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1200\/JCO.2007.12.6334","volume":"26","author":"HB Muss","year":"2008","unstructured":"Muss HB, Tu D, Ingle JN, Martino S, Robert NJ, Pater JL et al (2008) Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17. J Clin Oncol 26:1956\u20131964. https:\/\/doi.org\/10.1200\/JCO.2007.12.6334","journal-title":"J Clin Oncol"},{"key":"7866_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41416-019-0435-4","volume":"120","author":"K Ribi","year":"2019","unstructured":"Ribi K, Luo W, Colleoni M, Karlsson P, Chirgwin J, Aebi S et al (2019) Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. Br J Cancer 120:959\u2013967. https:\/\/doi.org\/10.1038\/s41416-019-0435-4","journal-title":"Br J Cancer"},{"key":"7866_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-018-4713-2","volume":"169","author":"LI Wagner","year":"2018","unstructured":"Wagner LI, Zhao F, Goss PE, Chapman JAW, Shepherd LE, Whelan TJ et al (2018) Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC clinical trials group (CCTG) MA.27 (E1Z03). Breast Cancer Res Treat 169:537\u201348. https:\/\/doi.org\/10.1007\/s10549-018-4713-2","journal-title":"Breast Cancer Res Treat"},{"key":"7866_CR41","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","volume":"23","author":"TJ Whelan","year":"2005","unstructured":"Whelan TJ, Goss PE, Ingle JN, Pater JL, Tu D, Pritchard K et al (2005) Assessment of quality of life in MA. 17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol 23:6931\u20136940. https:\/\/doi.org\/10.1200\/JCO.2005.11.181","journal-title":"J Clin Oncol"},{"key":"7866_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cct.2015.04.004","volume":"43","author":"E Vodicka","year":"2015","unstructured":"Vodicka E, Kim K, Devine EB, Gnanasakthy A, Scoggins JF, Patrick DL (2015) Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007-2013). Contemp Clin Trials 43:1\u20139. https:\/\/doi.org\/10.1016\/j.cct.2015.04.004","journal-title":"Contemp Clin Trials"},{"key":"7866_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev-med-060116-022831","volume":"69","author":"SH Voineskos","year":"2018","unstructured":"Voineskos SH, Nelson JA, Klassen AF, Pusic AL (2018) Measuring patient-reported outcomes: key metrics in reconstructive surgery. Annu Rev Med 69:467\u2013479. https:\/\/doi.org\/10.1146\/annurev-med-060116-022831","journal-title":"Annu Rev Med"},{"key":"7866_CR44","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1200\/JCO.22.02776","volume":"41","author":"D Osoba","year":"2023","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J (2023) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 41:5345\u20135350. https:\/\/doi.org\/10.1200\/JCO.22.02776","journal-title":"J Clin Oncol"},{"key":"7866_CR45","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","volume":"48","author":"K Cocks","year":"2012","unstructured":"Cocks K, King MT, Velikova G, de Castro G, Martyn St-James M, Fayers PM et al (2012) Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer 48:1713\u20131721. https:\/\/doi.org\/10.1016\/j.ejca.2012.02.059","journal-title":"Eur J Cancer"},{"key":"7866_CR46","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.19","author":"MA Franzoi","year":"2019","unstructured":"Franzoi MA, Rosa DD, Zaffaroni F, Werutsky G, Simon S, Jos\u00b4 J et al (2019) Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115) INTRODUCTION. J Global Oncol. https:\/\/doi.org\/10.1200\/JGO.19","journal-title":"J Global Oncol"},{"key":"7866_CR47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jamaoncol.2022.0864","volume":"8","author":"JN Samuel","year":"2022","unstructured":"Samuel JN, Booth CM, Eisenhauer E, Brundage M, Berry SR, Gyawali B (2022) Association of quality-of-life outcomes in cancer drug trials with survival outcomes and drug class. JAMA Oncol 8:879\u2013886. https:\/\/doi.org\/10.1001\/jamaoncol.2022.0864","journal-title":"JAMA Oncol"},{"key":"7866_CR48","doi-asserted-by":"publisher","first-page":"102797","DOI":"10.1016\/j.canep.2025.102797","volume":"96","author":"L Tolentino-Rodriguez","year":"2025","unstructured":"Tolentino-Rodriguez L, Chkeir M, Pofagi V, Ahindu I, Toniolo J, Erazo A et al (2025) Breast cancer characteristics in low- and middle-income countries: an umbrella review. Cancer Epidemiol 96:102797. https:\/\/doi.org\/10.1016\/j.canep.2025.102797","journal-title":"Cancer Epidemiol"},{"key":"7866_CR49","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_431272","author":"ME Martinez","year":"2024","unstructured":"Martinez ME, Schmeler KM, Lajous M, Newman LA (2024) Cancer screening in low- and middle-income countries. Am Soc Clin Oncol Educ Book. https:\/\/doi.org\/10.1200\/EDBK_431272","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"7866_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10549-022-06809-8","volume":"198","author":"RM Maschmann","year":"2023","unstructured":"Maschmann RM, De Jesus RG, Werutsky G, Rebelatto TF, Queiroz G, Simon SD et al (2023) Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III study (GBECAM 0115). Breast Cancer Res Treat 198:123\u2013130. https:\/\/doi.org\/10.1007\/s10549-022-06809-8","journal-title":"Breast Cancer Res Treat"},{"key":"7866_CR51","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1245\/s10434-018-6616-1","volume":"25","author":"SE Tevis","year":"2018","unstructured":"Tevis SE, James TA, Kuerer HM, Pusic AL, Yao KA, Merlino J et al (2018) Patient-reported outcomes for breast cancer. Ann Surg Oncol 25:2839\u20132845. https:\/\/doi.org\/10.1245\/s10434-018-6616-1","journal-title":"Ann Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07866-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07866-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07866-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:39:20Z","timestamp":1767789560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07866-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7866"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07866-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"26"}}